Lucy Smith

Dr. Lucy Smith

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2022 in Bioengineering & Translational Medicine
Verified
Journal Article
Open access
KGKirsty Goncalves
Kirsty Goncalves
PGPaola De Los Santos Gomez
Paola De Los Santos Gomez
LCLydia Costello
Lydia Costello
LSLucy Smith
Lucy Smith
HMHugh Mead
Hugh Mead
SPStefan Przyborski
Stefan Przyborski
Human skin equivalents (HSEs) are a popular technology due to limitations in animal testing, particularly as they recapitulate aspects of structure and function of human skin. Many HSEs contain two basic cell types to model dermal and epidermal compartments, however this limits their application, particularly when investigating the effect of exogenous stressors on skin health. We describe the development of a novel platform technology that accurately replicates skin pigmentation in vitro. Through incorporation of melanocytes, specialized pigment producing cells, into the basal layer of the epidermis we are able to re‐create skin pigmentation in vitro. We observe apical distribution of melanin within keratinocytes and formation of supranuclear caps (SPNCs), only when the epidermal compartment is co‐cultured with a dermal compartment, leading to the conclusion that fibroblast support is essential for correct pigment organization. We also evaluate the commonly observed phenomenon that pigmentation darkens with time in vitro, which we further explore through mechanical exfoliation to remove a build‐up of melanin deposits in the stratum corneum. Finally, we demonstrate the application of a pigmented HSE to investigate drug modulation of skin tone and protection from UV‐induced damage, highlighting the importance of such a model in the wider context of skin biology.

14 February 2020 in Interface Focus
Verified
Journal Article
Closed access
HHHenry William Hoyle
Henry William Hoyle
LSLucy Smith
Lucy Smith
RWR. J. Williams
R. J. Williams
SPStefan Przyborski
Stefan Przyborski
As the field of tissue engineering continues to advance rapidly, so too does the complexity of cell culture techniques used to generatein vitrotissue constructs, with the overall aim of mimicking thein vivomicroenvironment. This complexity typically comes at a cost with regards to the size of the equipment required and associated expenses. We have developed a small, low-cost bioreactor system which overcomes some of the issues of typical bioreactor systems while retaining a suitable scale for the formation of complex tissues. Herein, we have tested this system with three cell populations/tissues: the culture of hepatocellular carcinoma cells, where an improved structure and basic metabolic function is seen; the culture of human pluripotent stem cells, in which the cultures can form more heterogeneous tissues resembling thein vivoteratoma andex vivoliver tissue slices, in which improved maintenance of cellular viability is seen over the 3 days tested. This system has the flexibility to be used for a variety of further uses and has the potential to provide a more accessible alternative to current bioreactor technologies.

28 September 2024 in Stem Cell Reviews and Reports
Verified
Journal Article
Open access
PDF file
LSLucy Smith
Lucy Smith
RQRebecca Quelch-Cliffe
Rebecca Quelch-Cliffe
FLFelicity Liu
Felicity Liu
AAAlejandro Hidalgo Aguilar
Alejandro Hidalgo Aguilar
SPStefan Przyborski
Stefan Przyborski
Pluripotent stem cells have the ability to differentiate into all cells and tissues within the human body, and as a result they are attractive resources for use in basic research, drug discovery and regenerative medicine. In order to successfully achieve this application, starting cell sources ideally require in-depth characterisation to confirm their pluripotent status and their ability to differentiate into tissues representative of the three developmental germ layers. Many different methods to assess potency are employed, each having its own distinct advantages and limitations. Some aspects of this characterisation process are not always well standardised, particularly techniques used to assess pluripotency as a function. In this article, we consider the methods used to establish cellular pluripotency and subsequently analyse characterisation data for over 1590 human pluripotent cell lines from publicly available repositories in the UK and USA. In particular, we focus on the teratoma xenograft assay, its use and protocols, demonstrating the level of variation and the frequency with which it is used. Finally, we reflect on the implications of the findings, and suggest in vitro alternatives using modern innovative technology as a way forward. Graphical Abstract

23 July 2025 in Journal of Anatomy
Verified
Journal Article
Open access
PGPaola De Los Santos Gomez
Paola De Los Santos Gomez
RRRanjit Rai
Ranjit Rai
PRPamela Ritchie
Pamela Ritchie
LSLucy Smith
Lucy Smith
ASAmy Simpson
Amy Simpson
SPStefan Przyborski
Stefan Przyborski
Full‐thickness skin equivalents provide a platform for preclinical screening, streamlining the clinical trial process and reducing the need for animal testing while also providing a tool capable of fundamental insights into skin biology. Understanding the specific role of melanin dynamics across various skin tones is essential not only to better understand its function in photoprotection but is also better representative of a diverse population. Although pigmented skin equivalents (PSEs) have been reported in the literature, they rarely recapitulate the structural location of melanin within native keratinocytes, which is pivotal to its photoprotective role. This is due in part to the reliance of existing technologies on exogenous or animal‐derived extracellular matrix (ECM) constituents or the complete lack of a dermal compartment. In this study, we describe the development of novel PSEs representative of skin pigmentation phenotypes in vitro, which comprise fibroblast‐secreted endogenous ECM and a differentiated, well‐organised epidermis that resembles diverse skin tones. We demonstrate that these skin tones display morphological differences at a gross, histological and ultrastructural level. We then utilised the system to provide fundamental insights into the processes of melanogenesis, melanin transfer from melanocytes to keratinocytes, supranuclear cap formation and melanosome organisation within the epidermis. Quantification of melanosome dynamics allowed for comparison to native tissue and among skin tones, providing a detailed comparison among experimental conditions. This innovative technology enables a wide range of applications, such as studying pigmentation mechanisms in skin responses to external stimuli, disease modelling and drug testing involving the interactions between the epidermis and dermis.

22 April 2022 in Bioengineering
Verified
Journal Article
Open access
PDF file
AAAlejandro Hidalgo Aguilar
Alejandro Hidalgo Aguilar
LSLucy Smith
Lucy Smith
DODominic Owens
Dominic Owens
RQRebecca Quelch
Rebecca Quelch
SPStefan Przyborski
Stefan Przyborski
In vitro studies using human embryonic stem cells (hESCs) are a valuable method to study aspects of embryogenesis, avoiding ethical issues when using embryonic materials and species dissimilarities. The xenograft teratoma assay is often traditionally used to establish pluripotency in putative PSC populations, but also has additional applications, including the study of tissue differentiation. The stem cell field has long sought an alternative due to various well-established issues with the in vivo technique, including significant protocol variability and animal usage. We have established a two-step culture method which combines PSC-derived embryoid bodies (EBs) with porous scaffolds to enhance their viability, prolonging the time these structures can be maintained, and therefore, permitting more complex, mature differentiation. Here, we have utilised human embryonic stem cell-derived EBs, demonstrating the formation of tissue rudiments of increasing complexity over time and the ability to manipulate their differentiation through the application of exogenous morphogens to achieve specific lineages. Crucially, these EB-derived tissues are highly reminiscent of xenograft teratoma samples derived from the same cell line. We believe this in vitro approach represents a reproducible, animal-free alternative to the teratoma assay, which can be used to study human tissue development.

22 July 2024 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
ELEvon Low
Evon Low
LSLucy Smith
Lucy Smith
SMSatomi Miwa
Satomi Miwa
EFEdward Fielder
Edward Fielder
SPStefan Przyborski
Stefan Przyborski
TZThomas Von Zglinicki
Thomas Von Zglinicki